These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26313662)

  • 21. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
    Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.
    Li J; Schuler-Thurner B; Schuler G; Huber C; Seliger B
    Int Immunol; 2001 Dec; 13(12):1515-23. PubMed ID: 11717192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.
    Pan Y; Trojan J; Guo Y; Anthony DD
    PLoS One; 2013; 8(3):e58428. PubMed ID: 23526983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.
    Seliger B; Stoehr R; Handke D; Mueller A; Ferrone S; Wullich B; Tannapfel A; Hofstaedter F; Hartmann A
    Cancer Immunol Immunother; 2010 Apr; 59(4):529-40. PubMed ID: 19820934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The low rate of HLA class I molecules on the human embryonic stem cell line HS293 is associated with the APM components' expression level.
    Cabrera CM; Nieto A; Cortes JL; Montes RM; Catalina P; Cobo F; Barroso-Del-Jesus A; Concha A
    Cell Biol Int; 2007 Sep; 31(9):1072-8. PubMed ID: 17459733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression.
    Garbi N; Tiwari N; Momburg F; Hämmerling GJ
    Eur J Immunol; 2003 Jan; 33(1):264-73. PubMed ID: 12594855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transcriptional and epigenetic regulation of antigen processing machinery (APM) components and HLA-I in cervical cancers from Uighur women.
    Hasim A; Abudula M; Aimiduo R; Ma JQ; Jiao Z; Akula G; Wang T; Abudula A
    PLoS One; 2012; 7(9):e44952. PubMed ID: 23024775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
    Lazaridou MF; Gonschorek E; Massa C; Friedrich M; Handke D; Mueller A; Jasinski-Bergner S; Dummer R; Koelblinger P; Seliger B
    Oncoimmunology; 2020 Jun; 9(1):1774323. PubMed ID: 32923135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.
    Tanaka K; Tsuchikawa T; Miyamoto M; Maki T; Ichinokawa M; Kubota KC; Shichinohe T; Hirano S; Ferrone S; Dosaka-Akita H; Matsuno Y; Kondo S
    Int J Oncol; 2012 Apr; 40(4):965-74. PubMed ID: 22134332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dependence of elevated human leukocyte antigen class I molecule expression on increased heavy chain, light chain (beta 2-microglobulin), transporter associated with antigen processing, tapasin, and peptide.
    Johnson DR; Mook-Kanamori B
    J Biol Chem; 2000 Jun; 275(22):16643-9. PubMed ID: 10748183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP.
    Lee N; Geraghty DE
    J Immunol; 2003 Nov; 171(10):5264-71. PubMed ID: 14607927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential contribution of TAP and tapasin to HLA class I antigen expression.
    Belicha-Villanueva A; McEvoy S; Cycon K; Ferrone S; Gollnick SO; Bangia N
    Immunology; 2008 May; 124(1):112-20. PubMed ID: 18194274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
    Imanishi T; Kamigaki T; Nakamura T; Hayashi S; Yasuda T; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Kobe J Med Sci; 2006; 52(3-4):85-95. PubMed ID: 16855371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.
    Raffaghello L; Prigione I; Bocca P; Morandi F; Camoriano M; Gambini C; Wang X; Ferrone S; Pistoia V
    Oncogene; 2005 Jul; 24(29):4634-44. PubMed ID: 15897905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
    Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
    J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.